Women with chronic heart failure survive longer than their male counterparts, according to a large analysis of studies comprising data on more than 40,000 subjects.

PHILADELPHIA, Sept. 25 /PRNewswire/ -- Today, researchers presented new data showing molecular imaging agent 123I-mIBG can help cardiologists define risk in heart failure patients.

PRINCETON, N.J., May 17 /PRNewswire-FirstCall/ -- The ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) trial, the results of which were published in the May 18th, 2010 issue of the Journal of the American College of Cardiology, is a prospective study evaluating cardiac sympathetic nerve imaging using Iobenguane I 123 Injection (AdreView(TM)) for identifying symptomatic heart failure patients most likely to experience cardiac events. According to the study, the drug imaging results produced a model with four independent variables contributing to the prediction of the primary outcome events.

New research from the University of Alabama at Birmingham (UAB) suggests that the ability of right side of the heart to pump blood may be an indication of the risk of death to heart-failure patients whose condition is caused by low function by the left side of their heart.

SAN DIEGO, Nov.